Chronic kidney disease stage 5

Known as: ESRD, Renal Disease, End Stage, Disease (ESRD), End Stage Renal 
Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.
National Institutes of Health

Related topics

Related topics

49 relations
Acceptance status:Type:Pt:Form:NomBreath sounds:Finding:Point in time:^Patient:OrdinalCare by nephrologist prior to end stage renal disease therapy:Finding:Point in time:^Patient:OrdinalCertified program:Type:Pt:Dialysis facility:Nom:ESRD
(More)

Broader (2)

Chronic Kidney DiseasesKidney Failure, Chronic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5
Vitamin D insufficiency is related to erythropoietin resistance in chronic kidney disease (CKD). This study was conducted to… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Decrease in Irisin in Patients with Chronic Kidney Disease
Patients with chronic kidney disease have abnormal energy expenditure and metabolism. The mechanisms underlying altered energy… (More)
  • table 1
  • figure 1
  • table 3
  • table 2
  • figure 2
Is this relevant?
2012
2012
Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5)
To provide recommendations for the care of infants with stage 5 chronic kidney disease (CKD5). European Paediatric Dialysis… (More)
Is this relevant?
Review
2012
Review
2012
Nutritional management of stage 5 chronic kidney disease.
Nutrition is a critical issue in the management of patients with stage 5 chronic kidney disease (CKD). Malnutrition is common… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2009
2009
Conservatively managed patients with stage 5 chronic kidney disease--outcomes from a single center experience.
BACKGROUND Limited survival data are available on chronic kidney disease stage 5 (CKD 5) patients who opt for conservative… (More)
Is this relevant?
2008
2008
Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme.
BACKGROUND The clinical course of chronic kidney disease (CKD) in children is heterogeneous and has not been fully established… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.
BACKGROUND AND OBJECTIVES Albuminuria and inflammation predict cardiovascular events. Pentraxin 3, an inflammatory mediator… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
The guidelines proposed by the Kidney Disease Outcomes Quality Initiative (K/DOQI) suggested that intact parathyroid hormone… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.
BACKGROUND AND OBJECTIVES Plasma protein pentraxin 3 concentrations are elevated in a wide range of diseased states. However, no… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy.
BACKGROUND Phenylacetic acid (PAA) is a recently described uremic toxin that inhibits inducible nitric oxide synthase expression… (More)
Is this relevant?